BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld MedTech
BioWorld MedTech
Feb. 28, 2019
View Archived Issues
BGN's AI platform for ALS progression holds key to improving care and treatment
Read More
Stakeholders revolt over Medicare hit to ultrasound rates
Read More
Researchers plan phase III GDNF trial in Parkinson's; delivery device is key
Read More
Financings
Read More
Appointments and advancements
Read More
Product briefs
Read More
Regulatory front
Read More
Other news to note
Read More
BioWorld MedTech's Orthopedics Extra
Read More
Myoscience providing opioid alternatives with launch of Iovera Smart Tip system
Aiming to help a broader patient population and provide an alternative to opioids, Myoscience Inc., of Fremont, Calif., reported the commercial launch of the Iovera Smart Tip 309.
Read More
FDA gives breakthrough designation to first potential IVD test for Alzheimer's to Fujirebio
Read More
